Slingshot members are tracking this event:
Teva Settles Patent Litigation with AstraZeneca Allowing Teva to Commercialize Its Generic Version of Byetta (Exenatide Injection) in the United States
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Jun 23, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Byetta, Exenatide Injection, Patent Litigation